Clinical Trial Update: To Investigate the Real-world Efficacy and Safety of Sacituzumab Govitecan for HER2 Negative Metastatic Breast Cancer Patients in China.

View source ↗

Summary

This ClinicalTrials.gov entry describes a prospective real-world study assessing the efficacy and safety of Sacituzumab Govitecan in HER2-negative metastatic br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Breast Cancer Metastatic | Status: RECRUITING